Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 4Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 19Thoracic 13Genitourinary 12Head & Neck 9Breast 9Other hematologic neoplasm 7Tumor-Agnostic 6Lymphoid 6Gynecologic 6Dermatologic 5CNS 5Endocrine 3Sarcoma 2Other solid neoplasm 2Myeloid 2Plasma cell 1Other 1Classical hematology 1

Conditions

Melanoma 3Carcinoma, Basal Cell 2Skin Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 161Nivolumab 133Ipilimumab 78Cyclophosphamide 47Specimen Handling 42Magnetic Resonance Spectroscopy 38cemiplimab 35Biopsy 31fludarabine 28trametinib 24relatlimab 24binimetinib 23Interleukin-2 22fludarabine phosphate 20dabrafenib 20atezolizumab 19Opdualag 19CTLA-4 Antigen 19aldesleukin 18Radiotherapy 18Radiosurgery 18encorafenib 17Blood Specimen Collection 17avelumab 14Immunoglobulin G 14Disulfides 13lifileucel 11lenvatinib 11Paclitaxel 11Bevacizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observation × Dermatologic × 1 year × Clear all
NCT06539468 2026-04-14

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

University of Michigan Rogel Cancer Center

Phase NA Recruiting
200 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00003641 2026-02-25

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
1,150 enrolled 6 charts
Dermatologic

Melanoma

NCT06887348 2026-01-12

RPx

Replimune, Inc.

Recruiting
50 enrolled
DermatologicGastrointestinal

Carcinoma, Hepatocellular, Melanoma

NCT05561634 2025-09-30

RADIOSONIC

University Hospital, Lille

Phase 2 Recruiting
82 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT07092670 2025-09-05

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

Intergruppo Melanoma Italiano

Recruiting
270 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡